Also, as in the case with GLP-1 RAs, CKD was less recognized as an important CV complication compared with CAD (which may be a consequence of long-term use in practice and the influence of algorithms for assessing CV risk in the general population). The gene discussed is GLP1R; the disease is chronic kidney disease.